Inclusion criteria for all participants |
Available CSF, PET, CT or MRI data to evaluate the presence/absence of neurodegeneration (preferably within 1 year of inclusion in this study) |
Absence of ocular conditions that could influence tear biochemical parameters (including eye infection, eye inflammation, eye surgery within the last 28 days or other acute eye conditions) |
Absence of neurological or systemic chronic conditions known to interfere with retinal thickness (e.g. glaucoma, diabetes mellitus) |
Absence of ocular conditions interfering with OCT quality/retinal thickness: e.g. severe cataract, age-related macular degeneration, and glaucoma |
Written informed consent obtained and documented |
Age > 50 years |
No indications that follow-up (up to 24 months) is not possible |